- Study type: Randomised Clinical Trial, Prevention
- Study type descriptors: Randomised controlled trial, Multicentre
- Objective: To evaluate the vaccine effectiveness of the COVID-19 vaccine, mRNA-1273, in adults aged 50-64 years without known risk factors for severe COVID-19 infection
- Number of participants enrolled: Enrollment data not available
- Study enrolling from to
- Study includes follow-up for 6 months
- Standardisation: ICD-10
Study Data
- Adults (18-64 years)
- General population
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Vaccination
- Spikevax
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to